<unk>  is an immunological agent that is FDA approved for the treatment of patients 18 years of age or older with hairy cell leukemia and indicated as adjuvant to surgical treatment in patients 18 years of age or older with malignant melanoma who are free of disease but at high risk for systemic recurrence, within 56 days of surgery,AIDS-Related Kaposi's Sarcoma and condylomata acuminata. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include "flu-like" symptoms, particularly fever, headache, chills, myalgia, fatigue neutropenia , fever , myalgia , anorexia , vomiting/nausea , increased SGOT , headache , chills , depression , diarrhea , alopecia , altered taste sensation , dizziness/vertigo , and anemia ..
Interferon alfa-2b
Interferon alfa-2a
Interferon Alfa-n3
Pegylated interferon alfa-2a
Pegylated interferon alfa-2b
Interferon type I
Peginterferon Beta-1a
Pegylated interferon alpha